Concurrent Technologies PLC
LSE:CNC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
CVS Health Corp
NYSE:CVS
|
Health Care
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
Pharmaceuticals
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
Pharmaceuticals
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Nextera Energy Inc
NYSE:NEE
|
Utilities
|
| US |
|
Starbucks Corp
NASDAQ:SBUX
|
Hotels, Restaurants & Leisure
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
70.5
148.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
CVS Health Corp
NYSE:CVS
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Merck & Co Inc
NYSE:MRK
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Eli Lilly and Co
NYSE:LLY
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Nextera Energy Inc
NYSE:NEE
|
US |
|
|
Starbucks Corp
NASDAQ:SBUX
|
US |
This alert will be permanently deleted.
Concurrent Technologies PLC
Concurrent Technologies PLC
Gross Profit
Concurrent Technologies PLC
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Concurrent Technologies PLC
LSE:CNC
|
Gross Profit
£18.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
12%
|
|
|
Xaar PLC
LSE:XAR
|
Gross Profit
£23.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-10%
|
|
Concurrent Technologies PLC
Glance View
Concurrent Technologies Plc is engaged in the development, manufacture, and marketing of single board computers for system integrators and original equipment manufacturers. The company is headquartered in Colchester, Essex and currently employs 104 full-time employees. The Company’s core product range is central processing unit (CPU) boards, designed using Intel processors including the 11th generation embedded Intel Core and Intel Xeon processors. These CPU boards, together with complementary accessory products such as switches, storage and I/O boards are designed to be compliant with the CompactPCI , OpenVPX, VME, AMC and XMC open architecture standards. The Company’s products also support various operating systems including Microsoft Windows, Linux, Solaris, QNX and VxWorks. The Company’s sensor open systems architecture (SOSA) consortium is a commercial off-the-shelf (COTS) based open standards initiative that provides reconfigurable, upgradable, and embedded computing capabilities in deployed platforms.
See Also
What is Concurrent Technologies PLC's Gross Profit?
Gross Profit
18.1m
GBP
Based on the financial report for Jun 30, 2024, Concurrent Technologies PLC's Gross Profit amounts to 18.1m GBP.
What is Concurrent Technologies PLC's Gross Profit growth rate?
Gross Profit CAGR 10Y
12%
Over the last year, the Gross Profit growth was 62%. The average annual Gross Profit growth rates for Concurrent Technologies PLC have been 16% over the past three years , 14% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
